AI Article Synopsis
- The extract from the plant Acanthopanax trifoliatus exhibits strong inhibitory effects on various cancer cell lines, suggesting potential anticancer properties.
- Two new triterpenoids were identified from the plant, along with several known compounds, contributing new findings to the existing research on A. trifoliatus.
- The study highlights that specific isolated terpenoids demonstrated significant anticancer activity, proposing A. trifoliatus as a candidate for the development of health supplements targeting cancer prevention.
Article Abstract
The petroleum ether and ethyl acetate fractions of extract from an edible and medicinal plant Acanthopanax trifoliatus were found to show significant inhibitory effects against SF-268, MCF-7, HepG2 and NCI-H460 cancer cells. Two new ursane-type triterpenoids, acantrifoic acid C (1) and acantrifoic acid D (2), along with five known triterpenoids (3-7) and eight known diterpenoids (8-15) were obtained from these two fractions. To the best of our knowledge, this is the first report concerning the isolation of compounds (5-12, 14, 15) from A. trifoliatus. Among all the isolated compounds, 3, 5 and 8 from the ethyl acetate fraction showed the strongest inhibitory effects against cancer cells, while 12 and 13 from the petroleum ether fraction showed moderate activities. These terpenoid compounds may be responsible for the anticancer activities of A. trifoliatus. Our study provides the first evidence that terpenoids from A. trifoliatus exert anticancer activities and indicates that A. trifoliatus may be a useful edible plant for further development of anticancer health supplement.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12272-015-0655-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!